Fundraising Fox
/Companies
Sign in

FORE US Bio

Philadelphia, US · Founded 2022 · Delaware corporation · 3 known investors

Find your way into FORE US Bio

Sign up to see every warm intro you have to FORE US Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the FORE US Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in
Biotech

Founders & leadership

WH
William HinshawExecutiveHe brings over 30 years of pharmaceutical industry experience across commercial, financial, clinical development, and operations roles in global markets spanning multiple continents, with expertise in generics, vaccines, and specialty care.
JS
Jeff SacherChief Financial Officer
MR
Matthew RosChief Executive Officer, President and Secretary

Board

ECErez Chimovits
Erez ChimovitsBoard directorPartner at OrbiMed
GMGiovanni Mariggi
Giovanni MariggiBoard directorInvestor at Medicxi
MF
Matthew FoyBoard director
CL
Chandra LeoBoard director
MS
Michal SilverbergBoard director
RDRoberto De Ponti
Roberto De PontiBoard directorSenior Advisor at Claris Ventures
KB
Kim BlackwellBoard director
MB
Michael ByrnesBoard director
DW
Dieter WeinandBoard director

Investors · 3

MedicxiinferredLondonvia Giovanni Mariggi · board

How we know: board seat on SEC Form D · Not right? Tell us

OrbiMedinferredNew York · $1M – $75Mvia Erez Chimovits · board

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$132.5M disclosed across 2 rounds · 2023–2025

▶$70.4MraisedJul 2026 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HinshawExecutive Officer, Director
  • Erez ChimovitsDirector
  • Dieter WeinandDirector
  • Chandra LeoDirector
  • Rajeev DadooDirector
  • Giovanni MariggiDirector
  • Michael ByrnesExecutive Officer
  • Kim BlackwellDirector
Offering amount
$109.6M
Amount sold
$70.4M
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$62.1MraisedAug 2023 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff SacherExecutive Officer
  • Matthew RosExecutive Officer, Director
  • Michal SilverbergDirector
  • Meenu Chhabra KarsonDirector
  • Matthew FoyDirector
  • Kim BlackwellDirector
  • Dieter WeinandDirector
  • Roberto De PontiDirector
  • Chandra LeoDirector
  • Erez ChimovitsDirector
Offering amount
$122.6M
Amount sold
$62.1M
First sale
Aug 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are FORE US Bio's investors?
FORE US Bio's investors include 3B Future Health Fund, Medicxi, OrbiMed.
How much funding has FORE US Bio raised?
FORE US Bio has disclosed $132.5M raised across 2 rounds.
Where is FORE US Bio headquartered?
FORE US Bio is headquartered in Philadelphia, US.